A 47-year-old woman with ulcerative colitis (UC) was admitted to our hospital for renal dysfunction and progressive anemia. Colonoscopy revealed intestinal lesions and pathological findings showed intravascular large B-cell lymphoma (IVLBCL). According to the polymerase chain reaction analysis of sequential rectal specimens, we concluded that she suffered from intestinal BCL, not UC. After chemotherapy, her renal function progressed to nephrotic syndrome. The pathological findings of renal biopsy specimens indicated membranoproliferative glomerulonephritis (MPGN). Chemotherapy was continued and led to the remission of BCL and MPGN. We herein describe the first case of intestinal IVLBCL mimicking UC with secondary MPGN.
Introduction
Intravascular large B-cell lymphoma (IVLBCL) is a rare form of non-Hodgkin's lymphoma (NHL) characterized by the selective growth of neoplastic cells within the blood vessel lumina. The precise mechanisms responsible for this distinctive behavior remain largely unclear (1) . According to the World Health Organization classification, IVLBCL is defined as an extranodal B-cell lymphoma characterized by tumor involvement in the lumina of vessels, especially capillaries, with the exception of larger arteries and veins (2) . Since Pfleger and Tappeiner described the first case in 1959 (3), more than 300 cases have been reported to date, mostly in small series and case reports (4) . Intravascular growth of IVLBCL cells results in infiltration to various organs, such as the bone marrow, central nervous system (CNS), skin, lung, adrenal gland, liver, kidney, spleen, thyroid, pituitary gland, and gastrointestinal tract, without forming solid mass (5) . Among those organs, the gastrointestinal (GI) tract as the primary diagnostic site of IVLBCL is exceedingly rare, with only two reported cases (4, 6) .
Cases of membranoproliferative glomerulonephritis (MPGN) secondary to NHL are also rare. Da'as et al. reported that there were only 5 cases in the literature (7) . Regarding renal manifestations of IVLBCL, several reports, including the first report of IVLBCL in the kidney in 1981 (8) , indicated that infiltration of malignant lymphoid cells in the glomerular and peritubular capillaries was the direct cause of renal disorder (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . However, MPGN secondary to IVLBCL without evidence of lymphoma infiltration has not been previously reported.
We herein present the first case of IVLBCL mimicking ulcerative colitis (UC) accompanied by secondary MPGN. 
Case Report
A 47-year-old woman with a history of hypertension had been on medication (mesalazine) for UC, which was diagnosed in December 2009. In November 2010, she was referred to our hospital for treatment of a new rectal lesion. Colonoscopy showed redness in the cecum and an elevated lesion in the rectum. A histopathologic examination showed no malignancy. In September 2011, a urinalysis during an annual checkup revealed proteinuria and microscopic hematuria. The patient noticed edema in the bilateral lower extremities in September 2012. One month later, she was referred to our hospital for further examination of mild proteinuria and anemia. She had been followed up monthly without treatment. In March 2013, her renal function progressed (serum creatinine increased from 0.9 mg/dL to 1.1 mg/dL). As acute crescentic glomerulonephritis was suspected, prednisolone 20 mg/day was prescribed, and she was admitted to our hospital for further evaluation and treatment.
On this admission, the patient was in a good general condition. Her blood pressure was 122/68 mmHg. She had anemic palpebral conjunctiva. The lymph nodes, liver and spleen were not palpable. She had pitting edema in the bilateral lower extremities. Laboratory findings at the time of admission are shown in Table. She had mild anemia (hemoglobin 9.8 g/dL), hypoproteinemia and hypoalbuminemia [total protein (TP) 6.0 g/dL, albumin (Alb) 3.5 g/dL]. A urinalysis showed daily urinary excretion of 1.6 g protein with a normal renal function (Cr 0.9 mg/dL). Complement component 4 (C4) was slightly low in serological tests.
Her clinical course after this admission is shown in Fig. 1 . Because her anemia was exaggerated from 9.8 mg/ dL to 8.5 mg/dL in just two days and stool occult blood was positive, the patient underwent colonoscopy to investigate the cause of anemia. Colonoscopy showed redness in the ileocecum ( Fig. 2A ) and mass lesions in the ascending colon ( Fig. 2B ) and rectum (Fig. 2C ). Histopathological findings of biopsied specimens obtained from the ileocecum showed proliferation of large atypical cells in a small vessel (Fig. 3A) . Upon an immunohistochemical analysis, the atypical lymphoid cells were characterized to be CD34+ (within the blood vessel lumina) (Fig. 3B ), CD20+ ( Fig. 3C ), CD79a+, CD10-, CD5 (-), and BCL2+. The Ki-67 index was nearly 100% (Fig. 3D ). According to these findings, we confirmed the diagnosis of IVLBCL. Systemic 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) revealed high FDG uptakes in the ileocecum, ascending colon, and rectum (Fig. 4) , compatible with the colonoscopy findings. Cytology of the cerebral spinal fluid was class II, and there were no neurological findings.
According to the histological diagnosis, we performed R-CHOP chemotherapy (rituximab 550 mg/body, cyclophosphamide 1,100 mg/body, vincristine 2 mg/body, doxorubicin 74 mg/body). Prednisolone was omitted to avoid intestinal bleeding. The patient also received an intrathecal injection of methotrexate 15 mg/body, cytarabine 40 mg/body and prednisolone 10 mg/body to prevent CNS invasion. After chemotherapy, both TP and Alb decreased (TP 6.0 5.4 g/ dL, Alb 3.4 2.9 g/dL) and protein in the urine increased (1.6 g/day 6.4 g/day), compatible with nephrotic syndrome. A histopathological examination of the percutaneous renal biopsy specimens showed markedly enlarged and hyperlobulated glomeruli (Fig. 5A) . Occasional double contours of the glomerular basement membrane (Fig. 5B) were noted with periodic acid methenamine (PAM) silver staining. Electron micrography revealed mesangial and subendothelial hyaline deposits (Fig. 5C ). However, there were no findings associated with interstitial nephritis or tubular obstruction suggestive of drug-induced renal failure. Immunofluores- 
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cence studies showed granular deposition of IgG (Fig. 5D ) and C3 (Fig. 5E ). Given these findings, we made the diagnosis of MPGN. We decided to continue R-CHOP treatment for IVLBCL, under the assumption that MPGN was secondary to IVLBCL and the treatment for IVLBCL would resolve the renal symptoms. Five additional cycles of R-CHOP (rituximab 550 mg/ body, cyclophosphamide 1,100 mg/body, vincristine 2 mg/ body, doxorubicin 74 mg/body and prednisolone perorally in a tapered dosage following methylprednisolone semi-pulse therapy 125 mg/day for 4 days) were administered. Redness in the ileocecum and elevated lesions in the ascending colon and rectum subsequently disappeared on endoscopy. A histopathological examination of specimens obtained from colon and rectum showed no large atypical lymphoid cells. The patient achieved complete remission of IVLBCL. Regarding MPGN, microscopic hematuria, proteinuria as well as her edema in the lower extremities were improved. In addition, she lost 5 kg in body weight.
To confirm that her IVLBCL was a UC-related malignant lymphoma, we performed a polymerase chain reaction (PCR) analysis using two primer pairs designed to amplify the immunoglobulin heavy chain third-complementaritydetermining-region (CDR-III) (Fig. 6A ) on formalin-fixed tissues obtained by a rectal biopsy in 2010 (at the first referral to our hospital) and 2013 (when the diagnosis of IVLBCL was made). Both tissues samples produced similar PCR bands when the FR3a/VLJH pair was used (Fig. 6B) . A PCR reaction using the second primer pair did not produce specific bands due to the experimental conditions. Based on this result, we concluded that the patient suffered from intestinal IVLBCL, not UC, in 2010 followed by secondary MPGN several years later.
Disucussion
Although IVLBCL remains a rare disease and the precise mechanisms of its distinctive behavior are largely unknown, (1, 21) . IVL limited to the skin, the cutaneous variant, is a favorable presentation with clinical characteristics. However, patients in Asian countries typically show an aggressive clinical presentation, mostly associated with hemophagocytic syndrome (1, 22) . Due to the spectrum of clinical symptoms, the diagnosis of IVL tends to be difficult and delayed (5) . Among the primary diagnostic site of IVLBCL, the gastrointestinal (GI) tract is exceedingly rare. We could find only two reported cases in which the luminal GI tract was the primary diagnostic site of IVLBCL (4, 6) . In the present case, the inflammatory findings of specimens obtained by colonoscopy were compatible with UC, however, when considering the possibility of IVLBCL, the biopsy should be repeated. Intriguingly, Ponzoni suggested that in cases without evidence of IVLBCL elsewhere, a random tissue biopsy may be useful for a definitive demonstration (23) . Although a random skin biopsy is often performed, the gastrointestinal tract may also be a useful target because it is easy to biopsy, showing neoplastic cells within the lamina propria blood vessels (23) . In our case, mass lesions in the ascending colon (Fig. 2B ) and rectum were observed. The previous literature has described occasional cases of IVLBCL associated with other types of NHLs or solid NHL with an intravascular component. However, it remains unclear whether these double-component IVLBCLs share the same features.
In terms of kidney involvement and renal manifestations (8) . According to the review by Ponzoni and Ferreri (1), the frequency of renal involvement by IVLBCL is 21%. Histologically, renal involvement by lymphomas in general has been classified into two categories: intraglomerular growth type and tubulointerstitial diffuse invasion type (17) . Cases with the intraglomerular growth type were grouped as one renal manifestation of IVLBCL, with lymphoma cells observed in the glomerular vasculature. The tubulointerstitial type has been recognized as another type distinct from IVLBCL, due to the invasion of lymphoma cells into the tubulointerstitium (13) . The clinical findings induced by renal invasion of IVLBCL were categorized into the following two categories (13): acute renal failure (ARF) type and minimal change disease (MCD) type. The ARF type might be caused by the obstruction of glomerular circulation due to the invasion of lymphoid cells (17) , resulting in a loss of renal function. In these cases, the higher the proportion of glomeruli affected by the infiltration of tumor cells, the worse the renal function, consistent with the view that the presence of tumor cells impaired the glomerular function (13) . In the IVLBCL cases with the MCD type, histology of the renal biopsy revealed minimal glomerular lesions due to the absence of immune deposits in the glomeruli. It was suggested that the lymphocyte product released locally at the level of the glomerular capillary had an important role in the pathogenesis of minimal change lesions in IVLBCL cases (14) (15) (16) (17) . Previous publications of either the ARF or MCD type indicated renal infiltration of lymphoid cells pathologically. However, we did not acknowledge the existence of lymphocyte infiltration in the kidney, and the pathological findings of our case were compatible with MPGN. Therefore, we concluded that the renal lesion of the present case was MPGN secondary to IVLBCL. Marked bilateral nephromegaly is another major clinical feature in patients with the tubulointerstitial type of disease (13, 17) and systemic FDG-PET is useful to detect the spread of IVLBCL (24) . However, the present case showed no nephromegaly on the CT scan or an abnormal uptake of isotopes on FDG-PET, which further excludes the diagnosis of the tubulointerstitial type.
The pathogenesis of paraneoplastic glomerulonephritis remains unclear, however, it might be mediated by subepithelial immune complexes composed of tumor antigen and antibody or other nonlymphocyte antigens, including viral antigens (25) . Glomerulonephritis may also be related to the paraprotein deposition process that results in cryoglobulinemia or monoclonal immune deposition disease (26, 27) . The present case developed nephrotic syndrome after R-CHOP therapy. Neither paraproteins nor cryoglobulins were detected in our patient. There were no biochemical/histopathological findings of acute renal failure (indicating tumor lysis syndrome) or interstitial nephritis (indicating drugmediated renal failure). These results suggested that renal dysfunction was due to the exacerbation of IVLBCL, not an adverse effect of R-CHOP therapy. The renal biopsy played a critical role in decision-making to continue R-CHOP therapy by ruling out the possibility that R-CHOP therapy had aggravated the renal function.
When it comes to the treatment of renal failure caused by the direct invasion of IVLBCL, chemotherapy for IVLBCL was shown to improve the renal function in both ARF and MCD types (9) (10) (11) (12) (13) (14) (16) (17) (18) (19) . Similarly, the treatment for glomerular diseases associated with lymphoma other than IVLBCL is primarily directed at treating the underlying malignancy, and remission of the primary lymphoma is commonly accompanied by an improvement in the glomerular manifestations (25) (26) (27) (28) (29) . The present case demonstrated that MPGN secondary to IVLBCL, even without the invasion of lymphoma cells, could be successfully managed by treating the underlying malignancy.
In conclusion, we experienced a case of IVLBCL mimicking as UC with secondary MPGN. Both IVLBCL and MPGN are rare, therefore, MPGN secondary to IVLBCL is extremely rare. A histopathological examination of renal biopsy samples is critical for determining the diagnoses and therapeutic strategies.
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